Inactive Instrument
Oncorus, Inc. Stock
Stocks
ONCR
US68236R1032
Biotechnology & Medical Research
OTC Markets Traded| 1 day | -3.08% |
| Manager | Title | Age | Since |
|---|---|---|---|
Gina Balderas
COO | Chief Operating Officer | - | - |
| Corporate Officer/Principal | - | - | |
Chris German
AUD | Comptroller/Controller/Auditor | - | - |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 6/6/23 A | Other | Chief Executive Officer | 61,085 | 0.2341% | ||
| 12/28/22 A | Deerfield Management Co. LP
| Sell | Company | 336,235 | 1.2945% | |
| 12/22/22 A | Deerfield Management Co. LP
| Sell | Company | 73,384 | 0.2825% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -3.08% | +869.23% | - | - | 3.29M | |
| -0.62% | -1.87% | +46.31% | +56.99% | 63.77B | |
| +0.35% | +3.20% | +14.92% | +84.55% | 56.37B | |
| +0.53% | +1.96% | +15.37% | +106.81% | 54.62B | |
| -2.81% | -4.31% | +23.50% | +50.90% | 44.06B | |
| -0.33% | -1.93% | +20.15% | +98.45% | 42.11B | |
| +0.55% | +2.31% | +224.97% | +942.56% | 41B | |
| +3.27% | +47.96% | +112.67% | +96.48% | 34.92B | |
| +1.22% | -1.44% | +14.89% | +47.15% | 32.82B | |
| +0.89% | +20.55% | -42.03% | +373.03% | 24.7B | |
| Average | -0.00% | +7.54% | +47.86% | +206.32% | 43.82B | |
| Weighted average by Cap. | +0.18% | +5.44% | +48.50% | +186.13% |
Employees
64
